nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Ibuprofen—UGT2B7—urinary bladder cancer	0.00754	0.402	CrCbGaD
Esmolol—Ibuprofen—CXCL8—urinary bladder cancer	0.00426	0.227	CrCbGaD
Esmolol—Ibuprofen—PPARG—urinary bladder cancer	0.00295	0.157	CrCbGaD
Esmolol—Chlorphenesin—PTGS2—urinary bladder cancer	0.00279	0.148	CrCbGaD
Esmolol—Fatigue—Thiotepa—urinary bladder cancer	0.00156	0.00158	CcSEcCtD
Esmolol—Dysgeusia—Etoposide—urinary bladder cancer	0.00155	0.00158	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00155	0.00158	CcSEcCtD
Esmolol—Constipation—Thiotepa—urinary bladder cancer	0.00154	0.00157	CcSEcCtD
Esmolol—Pain—Thiotepa—urinary bladder cancer	0.00154	0.00157	CcSEcCtD
Esmolol—Oedema—Gemcitabine—urinary bladder cancer	0.00152	0.00155	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—urinary bladder cancer	0.00151	0.00154	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.00151	0.00154	CcSEcCtD
Esmolol—Irritability—Methotrexate—urinary bladder cancer	0.00151	0.00154	CcSEcCtD
Esmolol—Confusional state—Fluorouracil—urinary bladder cancer	0.0015	0.00153	CcSEcCtD
Esmolol—Convulsion—Cisplatin—urinary bladder cancer	0.0015	0.00153	CcSEcCtD
Esmolol—Oedema—Fluorouracil—urinary bladder cancer	0.00149	0.00152	CcSEcCtD
Esmolol—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00149	0.00152	CcSEcCtD
Esmolol—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00149	0.00151	CcSEcCtD
Esmolol—Skin disorder—Gemcitabine—urinary bladder cancer	0.00147	0.0015	CcSEcCtD
Esmolol—Anxiety—Cisplatin—urinary bladder cancer	0.00147	0.0015	CcSEcCtD
Esmolol—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00147	0.00149	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00147	0.00149	CcSEcCtD
Esmolol—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00146	0.00149	CcSEcCtD
Esmolol—Anorexia—Gemcitabine—urinary bladder cancer	0.00145	0.00147	CcSEcCtD
Esmolol—Urticaria—Thiotepa—urinary bladder cancer	0.00143	0.00146	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00143	0.00146	CcSEcCtD
Esmolol—Body temperature increased—Thiotepa—urinary bladder cancer	0.00143	0.00145	CcSEcCtD
Esmolol—Anorexia—Fluorouracil—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Esmolol—Hypotension—Gemcitabine—urinary bladder cancer	0.00142	0.00144	CcSEcCtD
Esmolol—Oedema—Cisplatin—urinary bladder cancer	0.00141	0.00144	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00141	0.00143	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—urinary bladder cancer	0.0014	0.00143	CcSEcCtD
Esmolol—Loss of consciousness—Etoposide—urinary bladder cancer	0.0014	0.00142	CcSEcCtD
Esmolol—Hypotension—Fluorouracil—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Esmolol—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00139	0.00141	CcSEcCtD
Esmolol—Convulsion—Etoposide—urinary bladder cancer	0.00138	0.0014	CcSEcCtD
Esmolol—Skin disorder—Cisplatin—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Esmolol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00137	0.00139	CcSEcCtD
Esmolol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00136	0.00139	CcSEcCtD
Esmolol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Esmolol—Chest pain—Etoposide—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Esmolol—Somnolence—Gemcitabine—urinary bladder cancer	0.00135	0.00137	CcSEcCtD
Esmolol—Anorexia—Cisplatin—urinary bladder cancer	0.00135	0.00137	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Esmolol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Esmolol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00133	0.00136	CcSEcCtD
Esmolol—Somnolence—Fluorouracil—urinary bladder cancer	0.00133	0.00135	CcSEcCtD
Esmolol—Hypotension—Cisplatin—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Esmolol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00132	0.00134	CcSEcCtD
Esmolol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Esmolol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00131	0.00133	CcSEcCtD
Esmolol—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00131	0.00133	CcSEcCtD
Esmolol—Fatigue—Gemcitabine—urinary bladder cancer	0.00131	0.00133	CcSEcCtD
Esmolol—Confusional state—Etoposide—urinary bladder cancer	0.00131	0.00133	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.0013	0.00132	CcSEcCtD
Esmolol—Constipation—Gemcitabine—urinary bladder cancer	0.0013	0.00132	CcSEcCtD
Esmolol—Pain—Gemcitabine—urinary bladder cancer	0.0013	0.00132	CcSEcCtD
Esmolol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.0013	0.00132	CcSEcCtD
Esmolol—Asthenia—Thiotepa—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Esmolol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00129	0.00131	CcSEcCtD
Esmolol—Dysuria—Methotrexate—urinary bladder cancer	0.00128	0.0013	CcSEcCtD
Esmolol—Pruritus—Thiotepa—urinary bladder cancer	0.00128	0.0013	CcSEcCtD
Esmolol—Pain—Fluorouracil—urinary bladder cancer	0.00128	0.0013	CcSEcCtD
Esmolol—Paraesthesia—Cisplatin—urinary bladder cancer	0.00127	0.00129	CcSEcCtD
Esmolol—Dyspnoea—Cisplatin—urinary bladder cancer	0.00126	0.00128	CcSEcCtD
Esmolol—Skin disorder—Etoposide—urinary bladder cancer	0.00126	0.00128	CcSEcCtD
Esmolol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Esmolol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00125	0.00127	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—urinary bladder cancer	0.00124	0.0662	CrCbGaD
Esmolol—Anorexia—Etoposide—urinary bladder cancer	0.00123	0.00126	CcSEcCtD
Esmolol—Decreased appetite—Cisplatin—urinary bladder cancer	0.00123	0.00125	CcSEcCtD
Esmolol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00123	0.00125	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Esmolol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00122	0.00124	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—urinary bladder cancer	0.00122	0.00124	CcSEcCtD
Esmolol—Hypotension—Etoposide—urinary bladder cancer	0.00121	0.00123	CcSEcCtD
Esmolol—Pain—Cisplatin—urinary bladder cancer	0.00121	0.00123	CcSEcCtD
Esmolol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0012	0.00122	CcSEcCtD
Esmolol—Dysuria—Epirubicin—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Esmolol—Dizziness—Thiotepa—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Esmolol—Urticaria—Fluorouracil—urinary bladder cancer	0.00119	0.00121	CcSEcCtD
Esmolol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00118	0.0012	CcSEcCtD
Esmolol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Esmolol—Paraesthesia—Etoposide—urinary bladder cancer	0.00116	0.00119	CcSEcCtD
Esmolol—Dyspnoea—Etoposide—urinary bladder cancer	0.00116	0.00118	CcSEcCtD
Esmolol—Somnolence—Etoposide—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Esmolol—Vomiting—Thiotepa—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—urinary bladder cancer	0.00114	0.00116	CcSEcCtD
Esmolol—Headache—Thiotepa—urinary bladder cancer	0.00113	0.00115	CcSEcCtD
Esmolol—Decreased appetite—Etoposide—urinary bladder cancer	0.00113	0.00115	CcSEcCtD
Esmolol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Esmolol—Body temperature increased—Cisplatin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Esmolol—Fatigue—Etoposide—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Esmolol—Pain—Etoposide—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Esmolol—Constipation—Etoposide—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Esmolol—Asthenia—Gemcitabine—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Esmolol—Pruritus—Gemcitabine—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Esmolol—Nausea—Thiotepa—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Esmolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Esmolol—Pruritus—Fluorouracil—urinary bladder cancer	0.00106	0.00108	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Esmolol—Urticaria—Etoposide—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Esmolol—Body temperature increased—Etoposide—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Esmolol—Asthenia—Cisplatin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—urinary bladder cancer	0.000991	0.00101	CcSEcCtD
Esmolol—Dizziness—Fluorouracil—urinary bladder cancer	0.000987	0.00101	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—urinary bladder cancer	0.000985	0.001	CcSEcCtD
Esmolol—Chills—Methotrexate—urinary bladder cancer	0.00098	0.000999	CcSEcCtD
Esmolol—Vomiting—Gemcitabine—urinary bladder cancer	0.000965	0.000983	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.000963	0.000981	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—urinary bladder cancer	0.000957	0.000975	CcSEcCtD
Esmolol—Erythema—Methotrexate—urinary bladder cancer	0.000951	0.000969	CcSEcCtD
Esmolol—Headache—Gemcitabine—urinary bladder cancer	0.000951	0.000969	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000949	0.000967	CcSEcCtD
Esmolol—Flushing—Epirubicin—urinary bladder cancer	0.000949	0.000967	CcSEcCtD
Esmolol—Vomiting—Fluorouracil—urinary bladder cancer	0.000949	0.000967	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—urinary bladder cancer	0.000948	0.000966	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000939	0.000957	CcSEcCtD
Esmolol—Headache—Fluorouracil—urinary bladder cancer	0.000935	0.000952	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000934	0.000952	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—urinary bladder cancer	0.000931	0.000949	CcSEcCtD
Esmolol—Asthenia—Etoposide—urinary bladder cancer	0.00093	0.000947	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—urinary bladder cancer	0.000927	0.000945	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000927	0.000945	CcSEcCtD
Esmolol—Chills—Epirubicin—urinary bladder cancer	0.000917	0.000935	CcSEcCtD
Esmolol—Pruritus—Etoposide—urinary bladder cancer	0.000917	0.000934	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.000912	0.000929	CcSEcCtD
Esmolol—Nausea—Gemcitabine—urinary bladder cancer	0.000901	0.000918	CcSEcCtD
Esmolol—Vomiting—Cisplatin—urinary bladder cancer	0.000899	0.000916	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—urinary bladder cancer	0.000896	0.000913	CcSEcCtD
Esmolol—Erythema—Epirubicin—urinary bladder cancer	0.00089	0.000907	CcSEcCtD
Esmolol—Nausea—Fluorouracil—urinary bladder cancer	0.000886	0.000903	CcSEcCtD
Esmolol—Flushing—Doxorubicin—urinary bladder cancer	0.000878	0.000895	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000878	0.000895	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—urinary bladder cancer	0.000871	0.000888	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000858	0.000875	CcSEcCtD
Esmolol—Dizziness—Etoposide—urinary bladder cancer	0.000857	0.000873	CcSEcCtD
Esmolol—Chills—Doxorubicin—urinary bladder cancer	0.000849	0.000865	CcSEcCtD
Esmolol—Nausea—Cisplatin—urinary bladder cancer	0.00084	0.000856	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—urinary bladder cancer	0.000829	0.000845	CcSEcCtD
Esmolol—Convulsion—Methotrexate—urinary bladder cancer	0.000824	0.00084	CcSEcCtD
Esmolol—Vomiting—Etoposide—urinary bladder cancer	0.000824	0.00084	CcSEcCtD
Esmolol—Erythema—Doxorubicin—urinary bladder cancer	0.000823	0.000839	CcSEcCtD
Esmolol—Agitation—Epirubicin—urinary bladder cancer	0.000818	0.000833	CcSEcCtD
Esmolol—Headache—Etoposide—urinary bladder cancer	0.000812	0.000827	CcSEcCtD
Esmolol—Chest pain—Methotrexate—urinary bladder cancer	0.00081	0.000825	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000806	0.000822	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000804	0.000819	CcSEcCtD
Esmolol—Syncope—Epirubicin—urinary bladder cancer	0.000798	0.000813	CcSEcCtD
Esmolol—Confusional state—Methotrexate—urinary bladder cancer	0.000783	0.000797	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000782	0.000797	CcSEcCtD
Esmolol—Convulsion—Epirubicin—urinary bladder cancer	0.000771	0.000786	CcSEcCtD
Esmolol—Nausea—Etoposide—urinary bladder cancer	0.00077	0.000784	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000761	0.000776	CcSEcCtD
Esmolol—Chest pain—Epirubicin—urinary bladder cancer	0.000758	0.000772	CcSEcCtD
Esmolol—Agitation—Doxorubicin—urinary bladder cancer	0.000757	0.000771	CcSEcCtD
Esmolol—Anxiety—Epirubicin—urinary bladder cancer	0.000755	0.000769	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—urinary bladder cancer	0.000754	0.000768	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000752	0.000767	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00075	0.000765	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—urinary bladder cancer	0.000741	0.000755	CcSEcCtD
Esmolol—Anorexia—Methotrexate—urinary bladder cancer	0.00074	0.000754	CcSEcCtD
Esmolol—Syncope—Doxorubicin—urinary bladder cancer	0.000738	0.000753	CcSEcCtD
Esmolol—Confusional state—Epirubicin—urinary bladder cancer	0.000732	0.000746	CcSEcCtD
Esmolol—Oedema—Epirubicin—urinary bladder cancer	0.000726	0.00074	CcSEcCtD
Esmolol—Hypotension—Methotrexate—urinary bladder cancer	0.000725	0.000739	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000724	0.000738	CcSEcCtD
Esmolol—Shock—Epirubicin—urinary bladder cancer	0.000715	0.000728	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—urinary bladder cancer	0.000713	0.000727	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000712	0.000726	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—urinary bladder cancer	0.000705	0.000719	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000702	0.000716	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—urinary bladder cancer	0.000701	0.000714	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—urinary bladder cancer	0.000699	0.000712	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000697	0.00071	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000696	0.000709	CcSEcCtD
Esmolol—Anorexia—Epirubicin—urinary bladder cancer	0.000692	0.000706	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000692	0.000705	CcSEcCtD
Esmolol—Somnolence—Methotrexate—urinary bladder cancer	0.00069	0.000703	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—urinary bladder cancer	0.000686	0.000699	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000683	0.000696	CcSEcCtD
Esmolol—Hypotension—Epirubicin—urinary bladder cancer	0.000679	0.000692	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—urinary bladder cancer	0.000678	0.000691	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000675	0.000688	CcSEcCtD
Esmolol—Oedema—Doxorubicin—urinary bladder cancer	0.000672	0.000685	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00067	0.000683	CcSEcCtD
Esmolol—Fatigue—Methotrexate—urinary bladder cancer	0.000669	0.000682	CcSEcCtD
Esmolol—Pain—Methotrexate—urinary bladder cancer	0.000664	0.000676	CcSEcCtD
Esmolol—Shock—Doxorubicin—urinary bladder cancer	0.000661	0.000674	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000659	0.000672	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000653	0.000665	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000652	0.000665	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00065	0.000662	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000647	0.00066	CcSEcCtD
Esmolol—Somnolence—Epirubicin—urinary bladder cancer	0.000646	0.000658	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—urinary bladder cancer	0.000641	0.000653	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00064	0.000652	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000639	0.000652	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000631	0.000643	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—urinary bladder cancer	0.000628	0.00064	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000627	0.000639	CcSEcCtD
Esmolol—Fatigue—Epirubicin—urinary bladder cancer	0.000626	0.000638	CcSEcCtD
Esmolol—Pain—Epirubicin—urinary bladder cancer	0.000621	0.000633	CcSEcCtD
Esmolol—Constipation—Epirubicin—urinary bladder cancer	0.000621	0.000633	CcSEcCtD
Esmolol—Urticaria—Methotrexate—urinary bladder cancer	0.000617	0.000628	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000613	0.000625	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000603	0.000615	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000599	0.000611	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000598	0.00061	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—urinary bladder cancer	0.000597	0.000609	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000592	0.000603	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000584	0.000595	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00058	0.000591	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—urinary bladder cancer	0.000579	0.00059	CcSEcCtD
Esmolol—Urticaria—Epirubicin—urinary bladder cancer	0.000577	0.000588	CcSEcCtD
Esmolol—Pain—Doxorubicin—urinary bladder cancer	0.000575	0.000586	CcSEcCtD
Esmolol—Constipation—Doxorubicin—urinary bladder cancer	0.000575	0.000586	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000574	0.000585	CcSEcCtD
Esmolol—Asthenia—Methotrexate—urinary bladder cancer	0.000557	0.000567	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000554	0.000564	CcSEcCtD
Esmolol—Pruritus—Methotrexate—urinary bladder cancer	0.000549	0.00056	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—urinary bladder cancer	0.000534	0.000544	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000531	0.000541	CcSEcCtD
Esmolol—Asthenia—Epirubicin—urinary bladder cancer	0.000521	0.000531	CcSEcCtD
Esmolol—Pruritus—Epirubicin—urinary bladder cancer	0.000514	0.000524	CcSEcCtD
Esmolol—Dizziness—Methotrexate—urinary bladder cancer	0.000513	0.000523	CcSEcCtD
Esmolol—Vomiting—Methotrexate—urinary bladder cancer	0.000493	0.000503	CcSEcCtD
Esmolol—Headache—Methotrexate—urinary bladder cancer	0.000486	0.000495	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—urinary bladder cancer	0.000482	0.000491	CcSEcCtD
Esmolol—Dizziness—Epirubicin—urinary bladder cancer	0.00048	0.000489	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—urinary bladder cancer	0.000475	0.000485	CcSEcCtD
Esmolol—Vomiting—Epirubicin—urinary bladder cancer	0.000462	0.000471	CcSEcCtD
Esmolol—Nausea—Methotrexate—urinary bladder cancer	0.000461	0.00047	CcSEcCtD
Esmolol—Headache—Epirubicin—urinary bladder cancer	0.000455	0.000464	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—urinary bladder cancer	0.000444	0.000453	CcSEcCtD
Esmolol—Nausea—Epirubicin—urinary bladder cancer	0.000431	0.00044	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—urinary bladder cancer	0.000427	0.000435	CcSEcCtD
Esmolol—Headache—Doxorubicin—urinary bladder cancer	0.000421	0.000429	CcSEcCtD
Esmolol—Nausea—Doxorubicin—urinary bladder cancer	0.000399	0.000407	CcSEcCtD
